AstraZeneca to transfer U.S. pension plan
Share
WILMINGTON – The global pharmaceutical giant AstraZeneca recently informed employees that it is pursuing a buyout of its $1.3 billion pension plan for U.S. employees by a third-party insurer, likely affecting an unknown number of Delawareans. The news, first reported by Bloomberg, comes after the British-Swedish company reported booming revenues amid a year where it
Want to Read More?
Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.
Already an Insider? Log In.